Navigation Links
Astellas Signs United Nations Global Compact
Date:11/11/2011

TOKYO, November 11, 2011 /PRNewswire/ --

Astellas Pharma Inc. (Tokyo:4503, "Astellas") announced today that it is signing the United Nations Global Compact[1], which will further reinforce the company's commitment to corporate social responsibility (CSR) and ethical business practices around the world.

"We are committed to adopting the Global Compact and its 10 principles, further integrating them into the culture and day-to-day operations of our company and through Astellas' annual CSR Report[2] and other communications, we will make this commitment clear to our stakeholders and the general public," said Astellas President and CEO Yoshihiko Hatanaka. He added, "We believe joining the UN Global Compact highlights our CSR-based management which we are promoting to implement our raison d'être of 'contributing toward the health of people around the world through the provision of innovative and reliable pharmaceutical products."

[1] Global Compact (GP): GP is the world's largest corporate social responsibility initiative to implement the companies' sustainable growth. The United Nations GC asks companies to embrace, support and enact, within their sphere of influence, a set of 10 principles in areas regarding corporate social responsibility of human rights, labour standards, the environment and anti-corruption.

The United Nations Global Compact 10 Principles are as follows:

Human Rights

  • Principle 1: Businesses should support and respect the protection of internationally proclaimed human rights; and

SOURCE Astellas Pharma Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer
2. Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide
3. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
4. Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications
5. Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals 2010 Annual Stockholders Meeting
6. Astellas Announces Successful Completion of Initial Tender Offer for Shares of OSI and Announces Subsequent Offer Period
7. Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
8. Astellas Awards Scholarships to 12 Transplant Recipients and Donors Who Embody Hope, Courage and Achievement
9. Astellas Mobilizes 1,300+ Employees in the Americas to Participate in First Annual Changing Tomorrow Day
10. Although NeurogesX/Astellass Qutenza is Only Approved for Postherpetic Neuralgia, Surveyed U.S. Physicians are Likely to Prescribe It for All Neuropathic Pain Types
11. Astellas Announces Retirement of Donald Rice and Appointment of Sef Kurstjens as CEO and President of Agensys, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)...  Cardica, Inc. (Nasdaq: CRDC ) today announced ... quarter and year ended June 30, 2014, on Thursday, August ... a conference call at 4:30 p.m. Eastern Time to discuss ... business. Conference Call Details To access the live ... Time via phone, please dial 866-953-6859 from the ...
(Date:7/23/2014)... -- Global healthcare company GSK reports Q2 ... increased price competition and supply disruptions to its Consumer ... points out that the company is very much in transition, ... confident about long-term prospects as well as the investments ... Simon Dingemans adds that the company is ...
(Date:7/23/2014)... ENGLEWOOD, Colo. , July 23 2014 ... opening of its new headquarters, manufacturing and research facility: ... Englewood, CO 80112 Direct: (720) 437-6500 ... advanced, labor efficient, pharmaceutical drug manufacturing facility will be ... to produce the first batches of Ampion TM ...
Breaking Medicine Technology:Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results on Thursday, August 7, 2014 2Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado 2
... Pa., Feb. 16, 2011 AirPal, a medical device ... of allowance from the U.S. Patent Office for its ... for situations such as difficult airway management, laryngoscopies, diagnostic ... founded in 1982, now holds more than a dozen ...
... YORK, Feb. 16, 2011 Get content from ... The European Parliament is expected ... prevent falsified medicines from entering the legal distribution ... packages have reached patients in the last years. ...
Cached Medicine Technology:AirPal Receives Patent for Inflatable Patient Positioning Systems 2
(Date:7/23/2014)... of research suggesting a safe and effective role ... cancer, with fewer detrimental side effects and improved ... study will be published in final format today ... Endocrinology . , Breast cancer is the most ... States. Approximately 70% of breast cancers are diagnosed ...
(Date:7/23/2014)... of Biomedical Imaging and Bioengineering will host its second ... 2014 on the NIH campus. There will be ten ... breadth of NIBIB-funded research. , WHO: ... Rhodopsins as Optical Voltage Sensor, Quyen Nguyen, Univ. ... Nerve Imaging during Surgery, ...
(Date:7/23/2014)... 2014 The American Telemedicine Association ... twentieth annual meeting and tradeshow focused exclusively on ... attract over 5,000 attendees and more than 250 ... 3-5, 2015, in Los Angeles. , ATA’s annual ... professionals from researchers, clinicians, hospital and university administrators, ...
(Date:7/23/2014)... New York (PRWEB) July 23, 2014 ... continue to move forward in a federal multidistrict litigation ... Bernstein Liebhard LLP reports. According to an Order dated ... a hospital’s bid for payment of a $1,000 fee ... hip implant. , Among other things, the Order ...
(Date:7/23/2014)... Fragile X syndrome ( FXS ) is a ... other behaviors on the autistic spectrum, as well as ... of mental impairment and the most common cause of ... California, Riverside have published a study that ... FXS. Appearing online today (July 23) in the ...
Breaking Medicine News(10 mins):Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5Health News:ATA Seeks Speakers to Present at the World’s Largest Telemedicine, mHealth and Telehealth Conference 2Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 4Health News:Study links enzyme to autistic behaviors 2Health News:Study links enzyme to autistic behaviors 3
... 6, 2009) The American Association of Pharmaceutical Scientists ... Ph.D., to the position of Research Fellow at the ... she will begin work this week to develop effective ... appointment comes at the end of a collaborative effort ...
... 12th annual Boston Stroke Luncheon "Making the Stroke Connection" will ... Boston from 7:30 a.m. to 12 p.m. Activities include a ... End Stroke Ambassador Training, and an awards celebration lunch from ... Janet Wu. , Milton Resident Margaret Kelly-Hayes, EdD, ...
... big chunk of change" to make Jen Ross smile. This ... raise more than $1,000 for Custom Hearts , ... heart defects or heart disease."Now that we have a big chunk ... things that we,ve wanted to do for a year and a ...
... Misperceptions About Donation Are CommonRICHMOND, Va., April 14 ... organ and tissue donors is rising, the registry still ... a report card issued by Donate Life America this ... Americans, 72 percent of people want their decision to ...
... Nu Skin Enterprises, Inc. (NYSE: NUS ) ... to the market opening on April 30, 2009. Truman ... call with the investment community later that same day beginning ... expect to hear management discuss past results as well as ...
... Association Becomes Only Major Parkinson,s Organization to Launch ... Parkinson,s DiseaseSTATEN ISLAND, N.Y., April 14 The ... Center has launched a re-designed Web site, ... onset Parkinson,s disease (PD), their family members, friends, ...
Cached Medicine News:Health News:AAPS and FDA announce appointment of research fellow 2Health News:Milton resident receives the Helen B. Spaulding Community Conscience Award 2Health News:TAN's Efforts Produce 'Chunk of Change' for Children With Heart Defects 2Health News:While the Majority of Americans Express Interest in Organ and Tissue Donation, Too Few Take Steps to Register as Donors 2Health News:While the Majority of Americans Express Interest in Organ and Tissue Donation, Too Few Take Steps to Register as Donors 3Health News:New Young Onset Parkinson's Disease Web Site Goes Live 2Health News:New Young Onset Parkinson's Disease Web Site Goes Live 3
Mounted on a sturdy, molded headband,the Classic has a fully adjustable crown,strap and cushioning that adds to,your comfort....
The Convertible lets you attach the,High Lite optic directly to your loupes....
... is a product of AlloSource, one ... human tissue processing, and Interpore Cross, ... InterGro combines AlloGro DBM with ... deliver a unique bone graft that ...
Immunoassay for the detection of Group A streptococcal antigen directly from throat swab specimens. ,Rapid, accurate diagnosis assures prompt treatment....
Medicine Products: